Related Experiment Video
Updated: Jul 8, 2026

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Application of stem cells in cardiology: where we are and where we are going
José Marín-García1, Michael J Goldenthal
1The Molecular Cardiology and Neuromuscular Institute, Highland Park, New Jersey 08904, USA. tmci@att.net
Insights
Stem cell transplantation offers a promising approach to repair heart damage, addressing the limitations of current therapies for myocardial infarction and ischemia. This review explores various stem cell types and their potential in regenerative cardiology.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Background:
- Heart disease leads to irreversible loss of cardiomyocytes and vasculature.
- Native myocardial repair capacity and current therapies are insufficient for left ventricular remodeling.
- Cell transplantation is a potential therapeutic strategy for damaged myocardium.
Purpose of the Study:
- To review stem cell applications in research and clinical cardiology.
- To analyze various stem/progenitor cell types for myocardial repair.
- To discuss future directions and challenges in stem cell therapy for heart disease.
Main Methods:
- Review of current literature on stem cell transplantation for heart disease.
- Comparison of different stem/progenitor cell types (embryonic, fetal, myoblasts, bone marrow).
- Evaluation of myocardial disorders suitable for stem cell therapy.
Main Results:
- Stem cell transplantation is a viable approach for myocardial repair.
- Various stem cell types show potential, each with specific advantages and limitations.
- Understanding cell fusion and transdifferentiation is crucial for efficacy.
Conclusions:
- Stem cell therapy holds significant promise for treating heart disease.
- Further research is needed to overcome technological shortcomings and optimize clinical application.
- Personalized stem cell strategies may improve outcomes for myocardial repair.
Abstract:
Heart disease including myocardial infarction and ischemia is associated with the irreversible loss of cardiomyocytes and vasculature, both via apoptosis or necrosis. However, the native capacity for the renewal and repair of myocardial tissue is inadequate as have been current therapeutic measures to prevent left ventricular remodeling. Cell transplantation has emerged as a potentially viable therapeutic approach to directly repopulate and repair the damaged myocardium. A detailed analysis and a vision for future progress in stem cell applications, both in research and clinical cardiology are presented in this review, highlighting the use of a wide spectrum of stem/progenitor cell types including embryonic or fetal stem cells, myoblasts, and adult bone marrow stem cells. An up-to-date comparison of donor cell-types used, and evaluation of the myocardial disorders that might be most amenable to stem cell therapy are discussed. The roles that myocardial cell fusion and transdifferentiation play in stem cell transplantation, the specific shortcomings of available technologies, and recommendations for practical ways that these concerns might be overcome, are also presented.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Clinical Applications of Epidermal Stem Cells
Embryonic Stem Cells

